Answers are grounded in this paper and cite their sources.
Two additional cases are described with partial trisomy 4q, resulting from a de novo duplication of chromosome 4, involving segments q21-q28. This time a sibling is affected. The clinical manifestations are similar to other cases with de novo 4q duplication involving the same segments. Although a single distinctive phenotype has not been established, most reported cases of de novo duplication share a similar clinical spectrum depending on the specific duplicated segment of chromosome 4q. The major clinical manifestations are growth and psychomotor retardation, microcephaly, epicantic fold, antimongoloid slant of palpebral fissures, low-set and malformed auricles, high nasal bridge, long philtrum small mouth, micrognathia, short neck, additionally, one patient presented congenital heart disease, and both presented congenital pyloric hypertrophy stenosis, dorsal edema of the hands and feet, the hypertrichosis as the most important clinical manifestations. Diverse genes involved in neural, cardiovascular, acrorenal, and skeletal development—identified in molecular studies of the duplication—are reviewed; these genes are potentially responsible for the phenotypic anomalies reported in each chromosomal region. We reported the another family directly affected with the same de novo direct duplication in the literature of a rare chromosomal trisomy, as the second ovarian germline mosaicism case which was demonstrated through cytogenetic and molecular analysis, confirmed by fluorescent in situ hybridization (FISH) with a painting probe and microsatellites studies. Besides, deep in a clinical analysis of karyotype-phenotype correlation in each duplicated segment.
No takes yet. Share an insight, caveat, or question.
Nuño‐Arana et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: